LUKAS SCHEIBLER Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LUKAS SCHEIBLER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LUKAS SCHEIBLER. LUKAS SCHEIBLER is EVP of Research & Development in ACUCELA INC. ($M??????) and EVP of Translational Medicine in ACUCELA INC. ($M??????) and CHIEF INNOVATION OFFICER in Apellis Pharmaceuticals, Inc. ($APLS) and See Remarks in Apellis Pharmaceuticals, Inc. ($APLS).
Latest Insider Trading Transactions of LUKAS SCHEIBLER
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 11 2021 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | CHIEF INNOVATION OF ... | Payment of Exercise | F | 47.72 | 680 | 32,450 | 29,290 | 30 K to 29.3 K (-2.27 %) |
Feb 01 2021 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | CHIEF INNOVATION OF ... | Option Exercise | A | 44.90 | 11,250 | 505,125 | 11,250 | |
Feb 01 2021 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | CHIEF INNOVATION OF ... | Option Exercise | A | 44.90 | 45,000 | 2,020,500 | 45,000 | |
Feb 01 2021 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | CHIEF INNOVATION OF ... | Grant | A | 0.00 | 1,875 | 0 | 29,970 | 28.1 K to 30 K (+6.67 %) |
Feb 01 2021 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | CHIEF INNOVATION OF ... | Grant | A | 0.00 | 7,500 | 0 | 28,095 | 20.6 K to 28.1 K (+36.42 %) |
Feb 01 2021 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | CHIEF INNOVATION OF ... | Option Exercise | A | 44.90 | 11,250 | 505,125 | 11,250 | |
Feb 01 2021 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | CHIEF INNOVATION OF ... | Option Exercise | A | 44.90 | 45,000 | 2,020,500 | 45,000 | |
Feb 01 2021 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | CHIEF INNOVATION OF ... | Grant | A | 0.00 | 1,875 | 0 | 29,970 | 28.1 K to 30 K (+6.67 %) |
Feb 01 2021 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | CHIEF INNOVATION OF ... | Grant | A | 0.00 | 7,500 | 0 | 28,095 | 20.6 K to 28.1 K (+36.42 %) |
Dec 09 2020 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | CHIEF INNOVATION OF ... | Option Exercise | M | 26.73 | 7,482 | 199,994 | 137,518 | |
Dec 09 2020 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | CHIEF INNOVATION OF ... | Buy | M | 26.73 | 7,482 | 199,994 | 20,595 | 13.1 K to 20.6 K (+57.06 %) |
Feb 12 2020 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | See Remarks | Option Exercise | A | 44.33 | 56,250 | 2,493,563 | 56,250 | |
Feb 12 2020 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | See Remarks | Grant | A | 0.00 | 9,375 | 0 | 12,310 | 2.9 K to 12.3 K (+319.42 %) |
Feb 12 2019 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | See Remarks | Option Exercise | A | 13.85 | 85,000 | 1,177,250 | 85,000 | |
May 29 2018 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | See Remarks | Buy | P | 20.37 | 2,935 | 59,786 | 2,935 | 0 to 2.9 K |
Apr 17 2018 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | See Remarks | Option Exercise | A | 26.73 | 145,000 | 3,875,850 | 145,000 | |
Jul 18 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Option Exercise | M | 0.00 | 2,663 | 0 | 66,587 | |
Jul 18 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Sell | S | 6.50 | 1,250 | 8,125 | 11,108 | 12.4 K to 11.1 K (-10.11 %) |
Jul 18 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Buy | M | 0.00 | 2,663 | 0 | 12,358 | 9.7 K to 12.4 K (+27.47 %) |
Jun 20 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Option Exercise | M | 0.00 | 2,664 | 0 | 69,250 | |
Jun 20 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Sell | S | 6.95 | 1,300 | 9,035 | 9,695 | 11 K to 9.7 K (-11.82 %) |
Jun 20 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Buy | M | 0.00 | 2,664 | 0 | 10,995 | 8.3 K to 11 K (+31.98 %) |
May 18 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Option Exercise | M | 0.00 | 2,663 | 0 | 71,914 | |
May 18 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Sell | S | 6.15 | 1,275 | 7,841 | 8,331 | 9.6 K to 8.3 K (-13.27 %) |
May 18 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Buy | M | 0.00 | 2,663 | 0 | 9,606 | 6.9 K to 9.6 K (+38.36 %) |
Apr 17 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Option Exercise | M | 0.00 | 2,664 | 0 | 74,577 | |
Apr 17 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Sell | S | 6.48 | 1,320 | 8,554 | 6,943 | 8.3 K to 6.9 K (-15.97 %) |
Apr 17 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Buy | M | 0.00 | 2,664 | 0 | 8,263 | 5.6 K to 8.3 K (+47.58 %) |
Mar 20 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Option Exercise | M | 0.00 | 2,663 | 0 | 77,241 | |
Mar 20 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Sell | S | 7.10 | 1,250 | 8,875 | 5,599 | 6.8 K to 5.6 K (-18.25 %) |
Mar 20 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Buy | M | 0.00 | 2,663 | 0 | 6,849 | 4.2 K to 6.8 K (+63.62 %) |
Feb 21 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Option Exercise | M | 0.00 | 2,664 | 0 | 79,904 | |
Feb 21 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Sell | S | 8.10 | 1,450 | 11,745 | 4,186 | 5.6 K to 4.2 K (-25.73 %) |
Feb 21 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Buy | M | 0.00 | 2,664 | 0 | 5,636 | 3 K to 5.6 K (+89.64 %) |
Jan 20 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Option Exercise | M | 0.00 | 2,663 | 0 | 82,568 | |
Jan 20 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Sell | S | 8.70 | 1,475 | 12,833 | 2,972 | 4.4 K to 3 K (-33.17 %) |
Jan 20 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Buy | M | 0.00 | 2,663 | 0 | 4,447 | 1.8 K to 4.4 K (+149.27 %) |
Dec 27 2016 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Option Exercise | M | 0.00 | 2,664 | 0 | 85,231 | |
Dec 27 2016 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Sell | S | 8.18 | 880 | 7,198 | 1,784 | 2.7 K to 1.8 K (-33.03 %) |
Dec 27 2016 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Buy | M | 0.00 | 2,664 | 0 | 2,664 | 0 to 2.7 K |
Nov 21 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & D ... | Option Exercise | M | 0.00 | 2,663 | 0 | 87,895 | |
Nov 21 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & D ... | Sell | S | 9.35 | 2,663 | 24,891 | 0 | 2.7 K to 0 (-100.00 %) |
Nov 21 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & D ... | Buy | M | 0.00 | 2,663 | 0 | 2,663 | 0 to 2.7 K |
Nov 15 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & D ... | Sell | S | 9.44 | 1,774 | 16,745 | 0 | 1.8 K to 0 (-100.00 %) |
Oct 18 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & D ... | Option Exercise | M | 0.00 | 2,664 | 0 | 90,558 | |
Oct 18 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & D ... | Payment of Exercise | F | 11.48 | 890 | 10,220 | 1,774 | 2.7 K to 1.8 K (-33.41 %) |
Oct 18 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & D ... | Buy | M | 0.00 | 2,664 | 0 | 2,664 | 0 to 2.7 K |
Sep 20 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & D ... | Option Exercise | M | 0.00 | 2,663 | 0 | 93,222 | |
Sep 20 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & D ... | Sell | S | 9.53 | 2,663 | 25,382 | 0 | 2.7 K to 0 (-100.00 %) |
Sep 20 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & D ... | Buy | M | 0.00 | 2,663 | 0 | 2,663 | 0 to 2.7 K |
Aug 18 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & D ... | Option Exercise | M | 0.00 | 31,962 | 0 | 95,885 | |
Aug 18 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & D ... | Sell | S | 10.81 | 31,962 | 345,509 | 0 | 32 K to 0 (-100.00 %) |
Aug 18 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & D ... | Buy | M | 0.00 | 31,962 | 0 | 31,962 | 0 to 32 K |
Jul 14 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & D ... | Option Exercise | A | 15.41 | 87,555 | 1,349,223 | 87,555 | |
Jul 14 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & D ... | Option Exercise | A | 15.41 | 32,445 | 499,977 | 32,445 | |
Aug 19 2015 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Translationa ... | Option Exercise | A | 0.00 | 127,847 | 0 | 127,847 |
Page: 1